JCR Pharmaceuticals , Ltd. Profit Margin

JCR Pharmaceuticals , Ltd. (JCRRF) currently reports a profit margin of -8.72% as of September 2026. That compares with -7.9% in the prior-year period — down 10.4% year over year. That is below the sector sector average of 13.2%. Use the charts on this page to explore JCR Pharmaceuticals , Ltd.'s profit margin history and peer comparisons.

JCR Pharmaceuticals , Ltd.'s profit margin decreased from -7.9% to -8.72% — a 10.4% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

JCR Pharmaceuticals , Ltd.'s profit margin of -8.72% is lower than the its sector sector average of 13.2%. That is roughly 166.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but JCR Pharmaceuticals , Ltd.'s current -8.72% should be judged against industry norms (sector average: 13.2%) and against JCRRF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -8.72%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.2%. From there, open related valuation or income-statement pages for JCR Pharmaceuticals , Ltd., and consider following JCRRF for alerts when major investors trade the stock.